Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders. Cancer Chemother Pharmacol. 2003 Sep; 52(3):229-34.